Use of genetically engineered lactic acid bacteria for the treatment of crohn's disease

Crohn's Disease: Classification, Diagnosis and Treatment Options

Volumn , Issue , 2013, Pages 307-321

  LeBlanc, Jean Guy ^a,b   del Carmen, Silvina ^a   Langella, Philippe ^c   Bermudez Humaran, Luis ^c   Lima, Fernanda Alvarenga ^d   Turk, Meritxell Zurita ^d   Pontes, Daniela Santos ^d   Miyoshi, Anderson ^d   Azevedo, Vasco ^d   de LeBlanc, Alejandra de Moreno ^a  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^c UMR1319 MICALIS   (France)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antioxidant enzymes, interleukin 10; Croh s Disease; Genetically modified microorganisms; Lactic acid bacteria

Indexed keywords

EID: 84892262478     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (56)

1. LeBlanc, J. G., de Moreno de LeBlanc, A., Perdigón, G., Miyoshi, A., Rochat, T., Bermudez-Humaran, L., Langella, P., Sesma, F., & Azevedo, V. (2008). Anti-inflammatory properties of Lactic Acid Bacteria: Current knowledge, applications and prospects. Anti-Infective Agents in Medicinal Chemistry 7 148-54.
2. Makarova, K., Slesarev, A., Wolf, Y., Sorokin, A., Mirkin, B., Koonin, E., Pavlov, A., Pavlova, N., Karamychev, V., Polouchine, N., Shakhova, V., Grigoriev, I., Lou, Y., Rohksar, D., Lucas, S., Huang, K., Goodstein, D. M., Hawkins, T., Plengvidhya, V., Welker, D., Hughes, J., Goh, Y., Benson, A., Baldwin, K., Lee, J. H., Diaz-Muniz, I., Dosti, B., Smeianov, V., Wechter, W., Barabote, R., Lorca, G., Altermann, E., Barrangou, R., Ganesan, B., Xie, Y., Rawsthorne, H., Tamir, D., Parker, C., Breidt, F., Broadbent, J., Hutkins, R., O'Sullivan, D., Steele, J., Unlu, G., Saier, M., Klaenhammer, T., Richardson, P., Kozyavkin, S., Weimer, B., & Mills, D. (2006). Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A, 103, 15611-6.
3. Bolotin, A., Mauger, S., Malarme, K., Ehrlich, S. D., & Sorokin, A. (1999). Low-redundancy sequencing of the entire Lactococcus lactis IL1403 genome. A Van Leeuw J Microb, 76, 27-76.
4. NCBI. Microbial genomes. [online]; 2011; [cited]; Available from: http://www.ncbi.nlm.nih.gov/genomes/MICROBES/microbial_taxtree.html.
5. Miyoshi, A., Bermudez-Humaran, L., Pacheco de Azevedo, M., Langella, P., & Azevedo, V. (2010) In: Mozzi F, Raya R, Vignolo G, editors (Eds.), Biotechnology of Lactic Acid Bacteria Novel Applications (pp. 161-76). Ames, Iowa, USA: Blackwell Publishing.
6. Sybesma, W., Hugenholtz, J., de Vos, W. M., & Smid, E. J. (2006). Safe use of genetically modified lactic acid bacteria in food. Bridging the gap between consumers, green groups, and industry. Elect J Biotechnol, 9, 424-48.
7. Djordjevic, G. M., & Klaenhammer, T. R. (1998). Inducible gene expression systems in Lactococcus lactis. Mol Biotechnol, 9, 127-39.
8. Kuipers, O. P., Beerthuyzen, M. M., de Ruyter, P. G., Luesink, E. J., & de Vos, W. M. (1995). Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction. J Biol Chem, 270, 27299-304.
9. Mierau, I., & Kleerebezem, M. (2005). 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol, 68, 705-17.
10. Miyoshi, A., Jamet, E., Commissaire, J., Renault, P., Langella, P., & Azevedo, V. (2004). A xylose-inducible expression system for Lactococcus lactis. FEMS Microbiol Lett, 239, 205-12.
11. Guimaraes, V., Innocentin, S., Chatel, J. M., Lefevre, F., Langella, P., Azevedo, V., & Miyoshi, A. (2009). A new plasmid vector for DNA delivery using lactococci. Genet Vaccines Ther, 7, 4.
12. Innocentin, S., Guimaraes, V., Miyoshi, A., Azevedo, V., Langella, P., Chatel, J. M., & Lefevre, F. (2009). Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells. Appl Environ Microbiol, 75, 4870-8. Epub 2009 May 29.
13. Keshavarzian, A., Banan, A., Farhadi, A., Komanduri, S., Mutlu, E., Zhang, Y., & Fields, J. Z. (2003). Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut, 52, 720-8.
14. Lih-Brody, L., Powell, S. R., Collier, K. P., Reddy, G. M., Cerchia, R., Kahn, E., Weissman, G. S., Katz, S., Floyd, R. A., McKinley, M. J., Fisher, S. E., & Mullin, G. E. (1996). Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci, 41, 2078-86.
15. Sedghi, S., Fields, J. Z., Klamut, M., Urban, G., Durkin, M., Winship, D., Fretland, D., Olyaee, M., & Keshavarzian, A. (1993). Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis. Gut, 34, 1191-7.
16. Simmonds, N. J., Allen, R. E., Stevens, T. R., Van Someren, R. N., Blake, D. R., & Rampton, D. S. (1992). Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology, 103, 186-96.
17. Condon, S. (1987). Responses of lactic acid bacteria to oxygen. FEMS Microbiology Letters, 46, 269-80.
18. Ross, S. (1991). The involvement of oxygen radicals in microbicidal mechanism of leukocytes and macrophages. Klin Wochenschr, 69, 975-80.
19. Berlett, B. S., & Stadtman, E. R. (1997). Protein oxidation in aging, disease, and oxidative stress. J Biol Chem, 272, 20313-6.
20. Farr, S. B., & Kogoma, T. (1991). Oxidative stress responses in Escherichia coli and Salmonella typhimurium. Microbiol Rev, 55, 561-85.
21. Szatrowski, T. P., & Nathan, C. F. (1991). Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res, 51, 794-8.
22. Kruidenier, L., & Verspaget, H. W. (2002). Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous? Aliment Pharmacol Ther, 16, 1997-2015.
23. Kruidenier, L., van Meeteren, M. E., Kuiper, I., Jaarsma, D., Lamers, C. B., Zijlstra, F. J., & Verspaget, H. W. (2003). Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice. Free Radic Biol Med, 34, 753-65.
24. de Moreno de LeBlanc, A., del Carmen, S., Zurita-Turk, M., Santos Rochat, C., van de Guchte, M., Azevedo, V., Miyoshi, A., & LeBlanc, J. G. (2011). Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases. ISRN Gastroenterology, 1, 1-10
25. del Carmen, S., de Moreno de LeBlanc, A., Miyoshi, A., Santos Rochat, C., Azevedo, V., & LeBlanc, J. G. (2011). Application of probiotics in the prevention and treatment of ulcerative colitis and other inflammatory bowel diseases. Ulcers, 1, 1-13.
26. LeBlanc, J. G., del Carmen, S., Miyoshi, A., Azevedo, V., Sesma, F., Langella, P., Bermudez-Humaran, L. G., Watterlot, L., Perdigon, G., & de Moreno de LeBlanc, A. (2011). Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn's disease in mice. J Biotechnol, 151, 287-93.
27. Spyropoulos, B., Misiakos, E., Fotiadis, C., & Stoidis, C. (2010). Antioxidant Properties of Probiotics and Their Protective Effects in the Pathogenesis of Radiation-Induced Enteritis and Colitis. Digestive Diseases and Sciences, 1-10.
28. Han, W., Mercenier, A., Ait-Belgnaoui, A., Pavan, S., Lamine, F., van, S., II, Kleerebezem, M., Salvador-Cartier, C., Hisbergues, M., Bueno, L., Theodorou, V., & Fioramonti, J. (2006). Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm Bowel Dis, 12, 1044-52.
29. Carroll, I. M., Andrus, J. M., Bruno-Barcena, J. M., Klaenhammer, T. R., Hassan, H. M., & Threadgill, D. S. (2007). Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol, 293, G729-38.
30. Watterlot, L., Rochat, T., Sokol, H., Cherbuy, C., Bouloufa, I., Lefevre, F., Gratadoux, J. J., Honvo-Hueto, E., Chilmonczyk, S., Blugeon, S., Corthier, G., Langella, P., & Bermudez-Humaran, L. G. (2010). Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int J Food Microbiol, 144, 35-41.
31. Rochat, T., Miyoshi, A., Gratadoux, J. J., Duwat, P., Sourice, S., Azevedo, V., & Langella, P. (2005). High-level resistance to oxidative stress in Lactococcus lactis conferred by Bacillus subtilis catalase KatE. Microbiology, 151, 3011-8.
32. Rochat, T., Gratadoux, J. J., Gruss, A., Corthier, G., Maguin, E., Langella, P., & van de Guchte, M. (2006). Production of a heterologous nonheme catalase by Lactobacillus casei: an efficient tool for removal of H2O2 and protection of Lactobacillus bulgaricus from oxidative stress in milk. Appl Environ Microbiol, 72, 5143-9.
33. de Moreno de LeBlanc, A., LeBlanc, J. G., Perdigon, G., Miyoshi, A., Langella, P., Azevedo, V., & Sesma, F. (2008). Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice. J Med Microbiol, 57, 100-5.
34. Rochat, T., Bermudez-Humaran, L., Gratadoux, J. J., Fourage, C., Hoebler, C., Corthier, G., & Langella, P. (2007). Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice. Microb Cell Fact, 6, 1-10.
35. Noonpakdee, W., Sitthimonchai, S., Panyim, S., & Lertsiri, S. (2004). Expression of the catalase gene katA in starter culture Lactobacillus plantarum TISTR850 tolerates oxidative stress and reduces lipid oxidation in fermented meat product. Int J Food Microbiol, 95, 127-35.
36. Xiang, H., Wei, W., & Tan, H. (2003). Food-grade expression of human glutathione S-transferase and Cu/Zn superoxide dismutase in Lactococcus lactis. Biomol Eng, 20, 107-12.
37. Grangette, C., Nutten, S., Palumbo, E., Morath, S., Hermann, C., Dewulf, J., Pot, B., Hartung, T., Hols, P., & Mercenier, A. (2005). Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A, 102, 10321-6.
38. Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000). Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science, 289, 1352-5.
39. de Moreno de LeBlanc, A., LeBlanc, J. G., Perdigón, G., Miyoshi, A., Langella, P., Azevedo, V., & Sesma, F. (2008). Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice. J Med Microbiol, 58,
40. Marinho, F. A., Pacifico, L. G., Miyoshi, A., Azevedo, V., Le Loir, Y., Guimaraes, V. D., Langella, P., Cassali, G. D., Fonseca, C. T., & Oliveira, S. C. (2010). An intranasal administration of Lactococcus lactis strains expressing recombinant interleukin-10 modulates acute allergic airway inflammation in a murine model. Clin Exp Allergy, 40, 1541-51.
41. del Carmen, S., de Moreno de LeBlanc, A., Perdigon, G., Pereira, V. B., Azevedo, V., Miyoshi, A., & LeBlanc, J. G. (2012). Evaluation of the anti-inflammatory effect of milk fermented by a strain of IL-10 producing Lactococcus lactis using a murine model of Crohńs disease. J Mol Microbiol Biotechnol, 21, 138-146.
42. Braat, H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J. P., van Deventer, S. J., Neirynck, S., Peppelenbosch, M. P., & Steidler, L. (2006). A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol, 4, 754-9.
43. Asadullah, K., Sterry, W., & Volk, H. D. (2003). Interleukin-10 therapy-review of a new approach. Pharmacological reviews, 55, 241.
44. de Moreno de LeBlanc, A., del Carmen, S., Zurita-Turk, M., Santos Rocha, C., van de Guchte, M., Azevedo, V., Miyoshi, A., & LeBlanc, J. G. (2011). Importance of IL-10 Modulation by Probiotic Microorganisms in Gastrointestinal Inflammatory Diseases. ISRN Gastroenterology, 2011, 11.
45. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., & Muller, W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell, 75, 263-74.
46. Tilg, H., van Montfrans, C., van den Ende, A., Kaser, A., van Deventer, S. J., Schreiber, S., Gregor, M., Ludwiczek, O., Rutgeerts, P., Gasche, C., Koningsberger, J. C., Abreu, L., Kuhn, I., Cohard, M., LeBeaut, A., Grint, P., & Weiss, G. (2002). Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut, 50, 191-5.
47. Li, M. C., & He, S. H. (2004). IL-10 and its related cytokines for treatment of inflammatory bowel disease. World Journal of Gastroenterology, 10, 620-5.
48. Schotte, L., Steidler, L., Vandekerckhove, J., & Remaut, E. (2000). Secretion of biologically active murine interleukin-10 by Lactococcus lactis. Enzyme and Microbial Technology, 27, 761-5.
49. Steidler, L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B., Cox, E., Remon, J. P., & Remaut, E. (2003). Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol, 21, 785-9.
50. Huyghebaert, N., Vermeire, A., Neirynck, S., Steidler, L., Remaut, E., & Remon, J. P. (2005). Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10. Eur J Pharm Biopharm, 60, 349-59.
51. del Carmen, S., de Moreno de LeBlanc, A., Perdigon, G., Pereira, V. B., Azevedo, V., Miyoshi, A., & LeBlanc, J. G. (2012). Evaluation of the anti-inflammatory effect of milk fermented by a strain of IL-10 producing Lactococcus lactis using a murine model of Crohńs disease. J Mol Microbiol Biotechnol, 21, 138-146.
52. Tournoy, K. G., Kips, J. C., & Pauwels, R. A. (2000). Endogenous interleukin-10 suppresses allergen-induced airway inflammation and nonspecific airway responsiveness. Clin Exp Allergy, 30, 775-83.
53. Frossard, C. P., Steidler, L., & Eigenmann, P. A. (2007). Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization. J Allergy Clin Immunol, 119, 952-9.
54. Waeytens, A., Ferdinande, L., Neirynck, S., Rottiers, P., De Vos, M., Steidler, L., & Cuvelier, C. A. (2008). Paracellular entry of interleukin-10 producing Lactococcus lactis in inflamed intestinal mucosa in mice. Inflamm Bowel Dis, 14, 471-9.
55. Loos, M., Remaut, E., Rottiers, P., & De Creus, A. (2009). Genetically engineered Lactococcus lactis secreting murine IL-10 modulates the functions of bone marrow-derived dendritic cells in the presence of LPS. Scand J Immunol, 69, 130-9.
56. Mallon, P., McKay, D., Kirk, S., & Gardiner, K. (2007). Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev, CD005573.